COPE registry: Temporal Trends of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea

• Sponsor: Wonju Severance Christian Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04834843
• Collaborator: (none)
• Enrollment: 700,000
• Actual Duration (Months): 144

Study Details

Study Description

Brief Summary

Cardiovascular disease (CVD) is caused by atherosclerosis of the artery and is classified into coronary artery disease, cerebrovascular disease, and peripheral arterial disease, depending on the location of the artery and the target organs. However, since CVD share a similar pathophysiology and the probability of incidence of other CVD in CVD patients is very high. It is thought that CVD incidence and mortality can be reduced by predicting the degree of incidence of other CVD in CVD patients. The aim of this study is to investigate the incidence and mortality of other CVD diseases in CVD patients.

Condition or Disease	Intervention/Treatment	Phase
Coronary Artery Disease; Peripheral Artery Disease; Cardiovascular Diseases	Other: Observational study, no intervention

Study Design

• Study Type: Observational
• Actual Enrollment: 700000 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Temporal Trends in the Incidence, Treatment Patterns, and Outcomes of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea
• Actual Study Start Date: Jan 1, 2009
• Actual Primary Completion Date: Dec 31, 2018
• Actual Study Completion Date: Dec 31, 2020

Outcome Measures

Primary Outcome Measures

1. Incidence of coronary artery disease, cerebrovascular disease, peripheral arterial disease [Up to 10 years]

   Among all Koreans, percentage (%) of patients with a history of being diagnosed with CVD and underwent in-hospital treatment

Secondary Outcome Measures

1. 1-year mortality [Up to 1 year]

   The percentage (%) of any CVD related mortality

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Koreans who diagnosed with coronary artery disease between 2009 and 2018

• Koreans who diagnosed with peripheral artery disease between 2009 and 2018

• Koreans who diagnosed with cerebrovascular disease between 2009 and 2018

• more than 18 years old

Exclusion Criteria:

• less than 18 years old

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Wonju Severance Christian Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Dong-Hyuk Cho, Assistant professor, Wonju Severance Christian Hospital
• ClinicalTrials.gov Identifier: NCT04834843
• Other Study ID Numbers: 2020AN0279
• First Posted: Apr 8, 2021
• Last Update Posted: Apr 8, 2021
• Last Verified: Apr 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Cardiovascular Diseases; Coronary Artery Disease; Myocardial Ischemia; Coronary Disease; Peripheral Arterial Disease

Study Results

No Results Posted as of Apr 8, 2021